Accelrys Posts 1 Percent Revenue Dip in Q2, Net Income Rises | GenomeWeb

NEW YORK (GenomeWeb News) – Accelrys today reported that revenue for its second fiscal quarter decreased by 1 percent to $20 million from $20.1 million in the prior-year period.

For the three months ended Sept. 30, the company's net income climbed 50 percent to $1.8 million, or $0.07 per diluted share, from $1.2 million, or $0.04 per diluted share, for the same quarter of the previous year.

Second-quarter product development costs decreased 5 percent to $3.6 million from $3.8 million year-over-year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.